Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm: Tokyo Wednesday, January 15, 2025, 10:00 Hrs [IST] Chugai P ...

Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope: Tokyo Wednesday, January 15, 2025, 09:00 Hrs [IST] Daiichi Sankyo Com ...

Peethaambaran Kunnathoor, Chennai Wednesday, January 15, 2025, 08:00 Hrs [IST] ...

How smart packaging is transforming pharmaceutical supply chain in tackling medical waste: Jay Deepak Shah Wednesday, January 15, 2025, 08:00 Hrs [IST] The Indian pharmaceutical s ...

Healthcare sector rapidly adopting technologies to enhance diagnostics, cybersecurity & revenue cycle management: Nandita Vijayasimha, Bengaluru Wednesday, January 15, 2025, 08:00 ...

DGFT notifies updated export policy aligned with Finance Act 2024 to boost pharma trade efficiency: Shardul Nautiyal, Mumbai Wednesday, January 15, 2025, 08:00 Hrs [IST] In a majo ...

Bill, 2023 to remove stringent punishments such as imprisonment from some of the provisions of the Drugs and Cosmetics Act, 1940 and the Pharmacy Act, 1948. The Bill was first introduced in Lok Sabha ...

Panel recommends DoP to take steps to improve success rate in NIPERs: Gireesh Babu, New Delhi Wednesday, January 15, 2025, 08:00 Hrs [IST] Noting that a large number of students e ...

Parliamentary panel criticises govt for lapse in implementation of scheme for IVDs: Gireesh Babu, New Delhi Wednesday, January 15, 2025, 08:00 Hrs [IST] The Parliamentary Standing ...

DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...

Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...

Novartis, an innovative medicines company, announced that the company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ...